BRPI0501708A - dispositivo de liberação lenta por processo transdérmico de um medicamento contra o excesso de colesterol e método de produção de um dispositivo transdérmico - Google Patents

dispositivo de liberação lenta por processo transdérmico de um medicamento contra o excesso de colesterol e método de produção de um dispositivo transdérmico

Info

Publication number
BRPI0501708A
BRPI0501708A BRPI0501708A BRPI0501708A BR PI0501708 A BRPI0501708 A BR PI0501708A BR PI0501708 A BRPI0501708 A BR PI0501708A BR PI0501708 A BRPI0501708 A BR PI0501708A
Authority
BR
Brazil
Prior art keywords
transdermal
slow
producing
release device
excess
Prior art date
Application number
Other languages
English (en)
Inventor
Jean Marc Millet
Original Assignee
Jean Marc Millet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jean Marc Millet filed Critical Jean Marc Millet
Priority to BRPI0501708 priority Critical patent/BRPI0501708A/pt
Priority to PCT/BR2006/000090 priority patent/WO2006119598A2/en
Publication of BRPI0501708A publication Critical patent/BRPI0501708A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

DIPOSITIVO DE LIBERAçãO LENTA POR PROCESSO TRANSDéRMICO DE UM MEDICAMENTO CONTRA O EXECESSO DE COLESTEROL E MéTODO DE PRODUçãO DE UM DISPOSITIVO TRANSDéRMICO,o qual é caracterizado por prever um dispositivo bi-laminar,leberação lenta transdérmica constituída de uma matriz macromolecular flexível (2) de uma espessura de 0,15 0, 6 cm e de uma superfície entre 10 e 100 cm quadrados e apresentando de um lado um revestimento posterior (1), permitindo uma redução considerável (mais de 15 vezes) das doses diárias a serem asministradas no tratamento do excesso de colesterol,a matriz macromolecular contendo e liberando de maneira contínua durante um período de 1 a 4 meses 0, 05 a 18% por dias de seu peso total em ómega 3 e/ou estatina,pela superfície em contato com a pele do paciente sem precisar aderir de forma fixa e permanente à pele do mesmo.
BRPI0501708 2005-05-10 2005-05-10 dispositivo de liberação lenta por processo transdérmico de um medicamento contra o excesso de colesterol e método de produção de um dispositivo transdérmico BRPI0501708A (pt)

Priority Applications (2)

Application Number Priority Date Filing Date Title
BRPI0501708 BRPI0501708A (pt) 2005-05-10 2005-05-10 dispositivo de liberação lenta por processo transdérmico de um medicamento contra o excesso de colesterol e método de produção de um dispositivo transdérmico
PCT/BR2006/000090 WO2006119598A2 (en) 2005-05-10 2006-05-10 Transdermal device for the slow delivery of an omega-3-fatty acid, optionally in combination with a hmg coa reductase inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0501708 BRPI0501708A (pt) 2005-05-10 2005-05-10 dispositivo de liberação lenta por processo transdérmico de um medicamento contra o excesso de colesterol e método de produção de um dispositivo transdérmico

Publications (1)

Publication Number Publication Date
BRPI0501708A true BRPI0501708A (pt) 2007-05-02

Family

ID=37396906

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0501708 BRPI0501708A (pt) 2005-05-10 2005-05-10 dispositivo de liberação lenta por processo transdérmico de um medicamento contra o excesso de colesterol e método de produção de um dispositivo transdérmico

Country Status (2)

Country Link
BR (1) BRPI0501708A (pt)
WO (1) WO2006119598A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2940116B1 (fr) * 2008-12-22 2012-07-06 Philippe Perovitch Formulation pour l'administration d'hypolipemiant par voie trans-muqueuse buccale
US9107983B2 (en) 2010-10-27 2015-08-18 Warsaw Orthopedic, Inc. Osteoconductive matrices comprising statins
US8877221B2 (en) 2010-10-27 2014-11-04 Warsaw Orthopedic, Inc. Osteoconductive matrices comprising calcium phosphate particles and statins and methods of using the same
US9308190B2 (en) 2011-06-06 2016-04-12 Warsaw Orthopedic, Inc. Methods and compositions to enhance bone growth comprising a statin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2548021B1 (fr) * 1983-06-29 1986-02-28 Dick P R Compositions pharmaceutiques dermiques a action prolongee et continue a base d'acides gras essentiels
JP4062639B2 (ja) * 1996-12-23 2008-03-19 日本水産株式会社 皮膚外用剤
DE10056010A1 (de) * 2000-11-11 2002-05-16 Beiersdorf Ag Pflaster mit hautpflegenden Substanzen

Also Published As

Publication number Publication date
WO2006119598A2 (en) 2006-11-16
WO2006119598A3 (en) 2007-03-01

Similar Documents

Publication Publication Date Title
Ghaferi et al. Transdermal Drug Delivery Systems (TDDS): recent advances and failure modes
NZ597378A (en) Treatment of multiple sclerosis with laquinimod
WO2008151040A3 (en) Analgesic coated medical product
EP2392363A3 (en) Drug coated expandable devices
MXPA02012793A (es) Composicion de dilatacion rapida para la retencion gastrica y la liberacion controlada de agentes terapeuticos y formas de dosificacion de la composicion.
RU2004103074A (ru) Применение циклопамина при лечении псориаза
MX2009011857A (es) Metodo y aparato para formar microconductos multiples.
Bhaskar et al. Comparison of transdermal diclofenac patch with oral diclofenac as an analgesic modality following multiple premolar extractions in orthodontic patients: a cross over efficacy trial
EP2043637B8 (en) Methods and medicaments for administration of ibuprofen
JP6147874B2 (ja) 皮膚マスキング材
BRPI0411032A (pt) composição adesiva hidrófila, artigo médico, método para a fabricação da composição adesiva, e, dispositivo de administração transdérmica
WO2008067991A3 (en) Skin-friendly drug complexes for transdermal administration
AR054249A1 (es) Tratamiento de enfermedades del tejido conectivo de la piel
DE602004016376D1 (de) Kombination von et-743 mit 5-fluorouracil pro-drugs zur behandlung von krebs
AU2014203502B2 (en) Once-a-day replacement transdermal administration of fentanyl
CN1867305A (zh) 利用透皮一氧化氮生成剂治疗过度使用性肌腱病
CA2480683A1 (en) Assembled unit consisting of individually separable transdermal therapeutic systems
Predel et al. Diclofenac patch for the treatment of acute pain caused by soft tissue injuries of limbs: a randomized, placebo-controlled clinical trial
BR0116653A (pt) Medicamento contendo uma poliamina como substância ativa
KR20100005091U (ko) 뜸 기능을 갖는 자기 경혈 패치
Kalkan et al. An alternative treatment model: the combination therapy of narrow band ultraviolet B phototherapy and tacrolimus ointment 0.1% in biphasic amyloidosis
AR052152A1 (es) Producto farmaceutico para el tratamiento preventivo y terapeutico de trastornos del sueno
WO2006119598A3 (en) Transdermal device for the slow delivery of an omega-3-fatty acid, optionally in combination with a hmg coa reductase inhibitor
JP4189837B2 (ja) 薬剤投与貼付材
JP2008514376A5 (pt)

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired